The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Kolterman Orville G since year 2005.
The trader's CIK number is 1236394.
At the time of this reporting, Kolterman Orville G is the Sr VP Clinical and Regulatory of Amylin Pharmaceuticals Inc .
(stock ticker symbol AMLN).
See this page for all insider trading activities at Amylin Pharmaceuticals Inc .
Stock purchases, sales, and option exercises reported by insider Kolterman Orville G since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-03-10
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,608
2.45
13,712
2008-01-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,000
1.84
11,061
2008-01-15
AMLN
Amylin Pharmaceuticals Inc
Sale
6,000
35.42
212,500
2008-01-02
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
11.95
80,065
2008-01-02
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
37.20
249,252
2007-12-17
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
38.39
191,950
2007-12-17
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
5.73
28,650
2007-12-03
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
37.74
252,853
2007-12-03
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
3.28
21,982
2007-11-15
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
41.68
208,392
2007-11-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
5.73
28,650
2007-11-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
2.91
19,470
2007-11-01
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
44.02
294,915
2007-10-16
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
5.73
28,650
2007-10-16
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
47.70
238,475
2007-10-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
10.38
69,512
2007-10-01
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
49.77
333,442
2007-09-26
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
50.00
250,000
2007-09-26
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
5.73
28,650
2007-09-17
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
5.73
28,650
2007-09-17
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
48.74
243,710
2007-09-04
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
9.62
64,487
2007-09-04
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
48.97
328,113
2007-08-15
AMLN
Amylin Pharmaceuticals Inc
Sale
10,000
49.10
491,003
2007-08-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
10,000
14.28
142,810
2007-08-07
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
14.28
71,405
2007-08-07
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
50.00
250,000
2007-08-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
1,700
9.62
16,362
2007-08-01
AMLN
Amylin Pharmaceuticals Inc
Sale
1,700
46.50
79,050
2007-07-16
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
43.69
292,705
2007-07-16
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
8.42
56,391
2007-07-02
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
1.61
8,047
2007-07-02
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
41.16
205,809
2007-06-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
7.81
52,343
2007-06-15
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
42.99
288,031
2007-06-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
.31
1,565
2007-06-01
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
46.12
230,615
2007-05-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
2.03
13,607
2007-05-15
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
42.29
283,335
2007-05-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
.31
1,565
2007-05-01
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
41.12
205,583
2007-04-13
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
40.06
200,300
2007-04-13
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
2.91
14,530
2007-04-16
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
40.58
271,862
2007-04-16
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
.55
3,664
2007-03-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
.78
5,232
2007-03-15
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
38.20
255,930
2007-02-15
AMLN
Amylin Pharmaceuticals Inc
Sale
6,700
40.23
269,551
2007-02-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,700
.78
5,232
2007-02-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
14.38
71,875
2007-02-01
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
38.69
193,426
2007-01-16
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
.78
3,905
2007-01-16
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
41.54
207,712
2007-01-11
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
3.28
16,405
2007-01-11
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
40.00
200,000
2006-12-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
3.28
16,405
2006-12-01
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
40.03
200,150
2006-11-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
7.64
38,202
2006-11-01
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
44.02
220,100
2006-10-02
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
12.00
60,000
2006-10-02
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
43.57
217,846
2006-09-01
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
46.14
230,686
2006-09-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
5,000
12.00
60,000
2006-08-07
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
12,093
7.64
92,396
2006-08-07
AMLN
Amylin Pharmaceuticals Inc
Sale
5,000
46.93
234,640
2006-05-01
AMLN
Amylin Pharmaceuticals Inc
Sale
10,000
43.44
434,400
2006-05-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
10,000
.31
3,130
2006-04-03
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
10,000
.31
3,130
2006-04-03
AMLN
Amylin Pharmaceuticals Inc
Sale
10,000
48.51
485,100
2006-03-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
10,000
.31
3,130
2006-03-01
AMLN
Amylin Pharmaceuticals Inc
Sale
10,000
43.35
433,500
2006-02-01
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
10,000
.31
3,130
2006-02-01
AMLN
Amylin Pharmaceuticals Inc
Sale
10,000
42.00
420,000
2006-01-03
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
8,583
12.38
106,214
2006-01-03
AMLN
Amylin Pharmaceuticals Inc
Sale
8,583
40.01
343,405
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kolterman Orville G
(Sr VP Clinical and Regulatory of Amylin Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
